rs200662010

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000726.5(CACNB4):​c.44C>T​(p.Pro15Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000726 in 1,376,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P15R) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.3e-7 ( 0 hom. )

Consequence

CACNB4
NM_000726.5 missense

Scores

2
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.211

Publications

0 publications found
Variant links:
Genes affected
CACNB4 (HGNC:1404): (calcium voltage-gated channel auxiliary subunit beta 4) This gene encodes a member of the beta subunit family of voltage-dependent calcium channel complex proteins. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. The protein encoded by this locus plays an important role in calcium channel function by modulating G protein inhibition, increasing peak calcium current, controlling the alpha-1 subunit membrane targeting and shifting the voltage dependence of activation and inactivation. Certain mutations in this gene have been associated with idiopathic generalized epilepsy (IGE), juvenile myoclonic epilepsy (JME), and episodic ataxia, type 5. [provided by RefSeq, Aug 2016]
CACNB4 Gene-Disease associations (from GenCC):
  • episodic ataxia type 5
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14848301).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNB4NM_000726.5 linkc.44C>T p.Pro15Leu missense_variant Exon 1 of 14 ENST00000539935.7 NP_000717.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNB4ENST00000539935.7 linkc.44C>T p.Pro15Leu missense_variant Exon 1 of 14 1 NM_000726.5 ENSP00000438949.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.26e-7
AC:
1
AN:
1376974
Hom.:
0
Cov.:
31
AF XY:
0.00000147
AC XY:
1
AN XY:
678968
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30156
American (AMR)
AF:
0.00
AC:
0
AN:
28554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23716
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35132
South Asian (SAS)
AF:
0.0000131
AC:
1
AN:
76166
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4752
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1072504
Other (OTH)
AF:
0.00
AC:
0
AN:
56904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
13
DANN
Benign
0.84
DEOGEN2
Benign
0.10
T;.;.;.
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.72
T;T;T;T
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.15
T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N;.;.;N
PhyloP100
-0.21
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.0
N;.;.;N
REVEL
Benign
0.18
Sift
Benign
0.35
T;.;.;T
Sift4G
Benign
0.48
T;.;.;T
Polyphen
0.0
B;.;.;.
Vest4
0.17
MutPred
0.14
Gain of catalytic residue at P15 (P = 0.0042);Gain of catalytic residue at P15 (P = 0.0042);Gain of catalytic residue at P15 (P = 0.0042);Gain of catalytic residue at P15 (P = 0.0042);
MVP
0.76
MPC
0.62
ClinPred
0.061
T
GERP RS
-0.083
PromoterAI
-0.067
Neutral
Varity_R
0.039
gMVP
0.34
Mutation Taster
=97/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200662010; hg19: chr2-152955482; API